Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
New Hampshire (NH) Suid Case Registry Pilot
HIV Prevention and Substance Abuse Treatment Targeting Latino
National Cancer Prevention and Control Program
Biomedical Research Support
Comprehensive Community Development and Support Project
Recently added grants:
Plasmonically Enhanced Point-of-care Detection of Cardiac Biomarkers by a Smart Phone
Role of endothelin in hypertension-mediated inflammation and end-organ damage
The Structural Basis of Antiarrhythmic Drug Binding in Voltage-gated Ion Channels
Pittsburgh Innovation in Collaborative Training of Residents Alliance
Roles of TET2-dependent DNA demethylation intermediates in hematological malignancies
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM52207-10-0-1
Application #
7568639
Study Section
Project Start
2004-12-15
Project End
2009-12-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
/ University of Alabama Birmingham
$244,166
NIH 2007
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
Hill, Donald /
$233,463
NIH 2007
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
/
NIH 2007
N01 CA
Assay Development and Initial Pharmacology Studies with SMA-491
/
NIH 2007
N01 CA
/
Comments
Be the first to comment on this grant